These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Processing and Ex Vivo Expansion of Adipose Tissue-Derived Mesenchymal Stem/Stromal Cells for the Development of an Advanced Therapy Medicinal Product for use in Humans. Labedz-Maslowska A; Szkaradek A; Mierzwinski T; Madeja Z; Zuba-Surma E Cells; 2021 Jul; 10(8):. PubMed ID: 34440677 [TBL] [Abstract][Full Text] [Related]
3. Establishing a Quality Control System for Stem Cell-Based Medicinal Products in China. Yuan BZ Tissue Eng Part A; 2015 Dec; 21(23-24):2783-90. PubMed ID: 25471126 [TBL] [Abstract][Full Text] [Related]
4. Translation of a standardized manufacturing protocol for mesenchymal stromal cells: A systematic comparison of validation and manufacturing data. Rojewski MT; Lotfi R; Gjerde C; Mustafa K; Veronesi E; Ahmed AB; Wiesneth M; Körper S; Sensebé L; Layrolle P; Hellem S; Schrezenmeier H Cytotherapy; 2019 Apr; 21(4):468-482. PubMed ID: 30926359 [TBL] [Abstract][Full Text] [Related]
5. The future of Cochrane Neonatal. Soll RF; Ovelman C; McGuire W Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834 [TBL] [Abstract][Full Text] [Related]
6. Biodistribution of mesenchymal stem/stromal cells in a preclinical setting. Sensebé L; Fleury-Cappellesso S Stem Cells Int; 2013; 2013():678063. PubMed ID: 24222773 [TBL] [Abstract][Full Text] [Related]
7. In vivo safety profile and biodistribution of GMP-manufactured human skin-derived ABCB5-positive mesenchymal stromal cells for use in clinical trials. Tappenbeck N; Schröder HM; Niebergall-Roth E; Hassinger F; Dehio U; Dieter K; Kraft K; Kerstan A; Esterlechner J; Frank NY; Scharffetter-Kochanek K; Murphy GF; Orgill DP; Beck J; Frank MH; Ganss C; Kluth MA Cytotherapy; 2019 May; 21(5):546-560. PubMed ID: 30878384 [TBL] [Abstract][Full Text] [Related]
8. Standardization of Good Manufacturing Practice-compliant production of bone marrow-derived human mesenchymal stromal cells for immunotherapeutic applications. Wuchter P; Bieback K; Schrezenmeier H; Bornhäuser M; Müller LP; Bönig H; Wagner W; Meisel R; Pavel P; Tonn T; Lang P; Müller I; Renner M; Malcherek G; Saffrich R; Buss EC; Horn P; Rojewski M; Schmitt A; Ho AD; Sanzenbacher R; Schmitt M Cytotherapy; 2015 Feb; 17(2):128-39. PubMed ID: 24856898 [TBL] [Abstract][Full Text] [Related]
9. Manufacturing Mesenchymal Stromal Cells for the Treatment of Osteoarthritis in Canine Patients: Challenges and Recommendations. Ivanovska A; Wang M; Arshaghi TE; Shaw G; Alves J; Byrne A; Butterworth S; Chandler R; Cuddy L; Dunne J; Guerin S; Harry R; McAlindan A; Mullins RA; Barry F Front Vet Sci; 2022; 9():897150. PubMed ID: 35754551 [TBL] [Abstract][Full Text] [Related]
10. Towards the Standardization of Mesenchymal Stem Cell Secretome-Derived Product Manufacturing for Tissue Regeneration. Chouaib B; Haack-Sørensen M; Chaubron F; Cuisinier F; Collart-Dutilleul PY Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628774 [TBL] [Abstract][Full Text] [Related]
11. Pancreas-derived mesenchymal stromal cells share immune response-modulating and angiogenic potential with bone marrow mesenchymal stromal cells and can be grown to therapeutic scale under Good Manufacturing Practice conditions. Thirlwell KL; Colligan D; Mountford JC; Samuel K; Bailey L; Cuesta-Gomez N; Hewit KD; Kelly CJ; West CC; McGowan NWA; Casey JJ; Graham GJ; Turner ML; Forbes S; Campbell JDM Cytotherapy; 2020 Dec; 22(12):762-771. PubMed ID: 32828673 [TBL] [Abstract][Full Text] [Related]
12. When Origin Matters: Properties of Mesenchymal Stromal Cells From Different Sources for Clinical Translation in Kidney Disease. Calcat-I-Cervera S; Sanz-Nogués C; O'Brien T Front Med (Lausanne); 2021; 8():728496. PubMed ID: 34616756 [TBL] [Abstract][Full Text] [Related]
13. Ex vivo expanded mesenchymal stromal cell minimal quality requirements for clinical application. Torre ML; Lucarelli E; Guidi S; Ferrari M; Alessandri G; De Girolamo L; Pessina A; Ferrero I; Stem Cells Dev; 2015 Mar; 24(6):677-85. PubMed ID: 25517941 [TBL] [Abstract][Full Text] [Related]
14. Regenerative medicine strategies for hair growth and regeneration: A narrative review of literature. Shimizu Y; Ntege EH; Sunami H; Inoue Y Regen Ther; 2022 Dec; 21():527-539. PubMed ID: 36382136 [TBL] [Abstract][Full Text] [Related]
15. Manufacturing mesenchymal stromal cells for clinical applications: A survey of Good Manufacturing Practices at U.S. academic centers. Phinney DG; Galipeau J; Cytotherapy; 2019 Jul; 21(7):782-792. PubMed ID: 31182333 [TBL] [Abstract][Full Text] [Related]
16. Human platelet lysate in mesenchymal stromal cell expansion according to a GMP grade protocol: a cell factory experience. Becherucci V; Piccini L; Casamassima S; Bisin S; Gori V; Gentile F; Ceccantini R; De Rienzo E; Bindi B; Pavan P; Cunial V; Allegro E; Ermini S; Brugnolo F; Astori G; Bambi F Stem Cell Res Ther; 2018 May; 9(1):124. PubMed ID: 29720245 [TBL] [Abstract][Full Text] [Related]
17. Good Manufacturing Practice (GMP) Compliance for Phage Therapy Medicinal Products. Bretaudeau L; Tremblais K; Aubrit F; Meichenin M; Arnaud I Front Microbiol; 2020; 11():1161. PubMed ID: 32582101 [TBL] [Abstract][Full Text] [Related]
18. Optimization of Mesenchymal Stromal Cell (MSC) Manufacturing Processes for a Better Therapeutic Outcome. Fernández-Santos ME; Garcia-Arranz M; Andreu EJ; García-Hernández AM; López-Parra M; Villarón E; Sepúlveda P; Fernández-Avilés F; García-Olmo D; Prosper F; Sánchez-Guijo F; Moraleda JM; Zapata AG Front Immunol; 2022; 13():918565. PubMed ID: 35812460 [TBL] [Abstract][Full Text] [Related]
19. Safety Profile of Good Manufacturing Practice Manufactured Interferon γ-Primed Mesenchymal Stem/Stromal Cells for Clinical Trials. Guess AJ; Daneault B; Wang R; Bradbury H; La Perle KMD; Fitch J; Hedrick SL; Hamelberg E; Astbury C; White P; Overolt K; Rangarajan H; Abu-Arja R; Devine SM; Otsuru S; Dominici M; O'Donnell L; Horwitz EM Stem Cells Transl Med; 2017 Oct; 6(10):1868-1879. PubMed ID: 28887912 [TBL] [Abstract][Full Text] [Related]
20. Study on the Umbilical Cord-Mesenchymal Stem Cell Manufacturing Using Clinical-Grade Culture Medium. Kurogi H; Takijiri T; Sakumoto M; Isogai M; Takahashi A; Okubo T; Koike T; Yamada T; Nagamura-Inoue T; Sakaki-Yumoto M Tissue Eng Part C Methods; 2022 Jan; 28(1):23-33. PubMed ID: 35018815 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]